COL17A1 and type 2 diabetes mellitus: By using ELISA, we found that the prevalence of serum IgG-autoantibodies against folded BP180-NC16A or FL‐BP180 was similar among gliptin using and non-using T2D patients, but higher than we have previously found for healthy controls (7.5%) (30).